Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

6.86

-0.09 (-1.29%)

At close: Sep 4, 2025, 4:00 PM

7.00

+0.14 (2.04%)

After-hours: Sep 4, 2025, 7:13 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2016 - 2018
Gene and Cell Therapies	3.50M	Log In	Log In	Log In	Log In	Upgrade
Gene and Cell Therapies Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2018	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '18 Dec 31, 2018	2016 - 2018
United States	3.50M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	147.52%	Log In	Log In	Log In	Log In	Upgrade